Welcome to the e-CCO Library!

P084: Response to appendectomy in refractory Ulcerative Colitis appears based on two distinct inflammatory phenotypes
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beckerdrs., M.(1)*;Heuthorst, L.(2);van Roest, M.(1);van der Bilt, J.(3);Buskens, C.(2);Wildenberg, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P084: Secreted inflammatory protein profiles following treatment of ex-vivo human Ulcerative Colitis and Crohn’s Disease explants with licenced biologic therapies
Year: 2022
Source: ECCO'22
Authors: Corcoran, R.(1);O'Connell, F.(2);O'Sullivan, J.(2);Kevans, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P085 Deep profiling of the circulating immune cell landscape in inflammatory bowel disease by mass cytometry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Horn1,2, Z. Borek1,2, E. Mantzivi1, M. Urbicht3, D. Boesel1,2, S. Baumgart3, E. Sonnenberg1, D. Lissner1, B. Siegmund1, H. Mei3, A.N. Hegazy MD, PhD1

Created: Thursday, 30 January 2020, 10:12 AM
P085: Altered proportions of myeloid and plasmacytoid dendritic cells in children with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. F. Elshal1, 2, 3, 4, A. M. Aldahlawi2, 3, 5, O. I. Saadah*6, 7, J. P. McCoy8

Created: Friday, 22 February 2019, 9:49 AM
P085: Crohn’s disease patients under combined therapy with Azathioprine and Infliximab present persistent inflammation together with a counter regulatory response during clinical disease remission
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Duarte-Silva1,2, R. S. Parra*3, M. R. Feitosa3, O. Féres3, J. J. Ribeiro da Rocha3, C. R. d1, B. Cardoso1

Created: Friday, 22 February 2019, 9:41 AM
P085: Expression profiling of Wnt pathway genes in colon biopsies of patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Lu, C.(1);Shah, D.(1);Wijnands, A.(2);Oldenburg, B.(2);Yeh, W.C.(3);Vanhove, G.(4);Li, Y.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P085: Gut microbiota profile changes in patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Inčiūraitė, R.(1)*;Gedgaudas, R.(1);Lukosevicius, R.(1);Plingyte, K.(1);Muskieta, T.(1);Juzenas, S.(1);Kupcinskas, J.(1);Skieceviciene, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P085: Paneth cells translate dietary lipid exposure into gut inflammation
Year: 2022
Source: ECCO'22
Authors: Grabherr, F.(1);Meyer, M.(1);Schmitz, J.J.(1);Schwärzler, J.(1);Mayr, L.(1);Philipp, M.(1);Jukic, A.(1);Grander, C.(1);Tilg, H.(1);Adolph, T.E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P085: Safety analysis of vedolizumab: a reproductive toxicology study in rabbits
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Crawford*, M. Friedman

Created: Thursday, 21 February 2019, 9:14 AM
P085: The effect of vitamin D on macrophage function and polarization in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dionne S., Duchatellier C.-F., Seidman E.

Created: Wednesday, 20 February 2019, 10:36 AM
P086 Identification of constitutive modifications in plasma cells and B lymphocytes in patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.C. Marin1, S. Fernández-Tomé1, L. Ortega Moreno2, V. Martin Dominguez3, S. Casabona3, I. Becerro3, I. Mora-Gutiérrez1, I. Villacañas-Gil1, M. Baldan-Martin1, J.A. Moreno-Monteagudo3, C. Santander2, M. Chaparro2, D. Bernardo1,4,5, J.P. Gisbert2,5

Created: Thursday, 30 January 2020, 10:12 AM
P086: Eukaryotic microbial dysbiosis in treatment-naïve patients with newly diagnosed Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Goren*1,2, L. Reshef3, L. Godny1, K. Rabinowitz1, I. Dotan1,2, H. Yanai1,2

Created: Friday, 22 February 2019, 9:41 AM
P086: Glycosylation of T-cells as a new molecular biomarker in inflammatory bowel disease: an opportunity for new therapeutic strategies
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. M. Dias1, M. Pereira1, R. Marcos-Pinto2, A. Correia3, M. Vilanova3, C. Reis1, P. Lago2, S. S. Pinho*1

Created: Friday, 22 February 2019, 9:49 AM
P086: MMP-12, a novel mediator of nociception in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tranter M., Barakat F., Dogra H., Lindsay J., Croft N., Bulmer D.

Created: Wednesday, 20 February 2019, 10:36 AM
P086: Mucosal microbiota modulate host intestinal immune signatures in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Hu, S.(1,2);Bourgonje, A.R.(1);Gacesa, R.(1,2);Jansen, B.H.(1);Bangma, A.(1);Hidding, I.(1,2);Festen, E.A.M.(1);van Dullemen, H.M.(1);Visschedijk, M.C.(1);Dijkstra, G.(1);Harmsen, H.J.M.(3);Vich Vila, A.(1,2);Spekhorst, L.M.(1,4);Weersma, R.K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P086: Non-enzymatic serum antioxidant capacity is diminished in inflammatory bowel disease and is associated with severity of inflammation in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Neubauer1*, M. Matusiewicz2, I. Bednarz-Misa2, P. Lewandowska2, M. Krzystek-Korpacka2

Created: Thursday, 21 February 2019, 9:14 AM
P086: Sirtuin 7 inhibitor attenuates colonic mucosal immune activation in mice–potential therapeutic target in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, S.H.(1)*;Jeen, Y.T.(1);Jeon, H.J.(1);Kim , E.S.(1);Keum, B.(1);Chun, H.J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P086: Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon immune dysregulation and intestinal permeability in a stress-induced colonic inflammation
Year: 2021
Source: ECCO'21 Virtual
Authors: Martin-Hernández, D.(1);Robledo Montaña, J.(2);López-Gutiérrez, I.(2);González-Prieto, M.(2);González Bris, Á.(2);Ulecia-Morón, C.(2);MacDowell, K.(2);Tendilla-Beltrán, H.(2);Moreno, B.(2);Calleja-Rodríguez, N.(2);Rodríguez-Mascarenhas, S.(2);Caso, J.R.(2);García-Bueno, B.(2);Marín-Jiménez, I.(3);Leza, J.C.(2);Menchen Viso, L.A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P087 Biomarkers of elastin degradation differentiate between clinically inactive and active disease in ulcerative colitis patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Pehrsson1, V. Domislović2, M.A. Karsdal1, M. Brinar2, A. Barisic3, Z. Krznaric2, T. Manon-Jensen1, J.H. Mortensen1

Created: Thursday, 30 January 2020, 10:12 AM
P087: A novel OGR1 (GPR68) inhibitor attenuates inflammation in a murine model of Acute Colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Baebler*, C. Maeyashiki, P. Busenhart, M. Schwarzfischer, K. Atrott, S. Lang, M. Spalinger, M. Scharl, G. Rogler, C. de Vallière

Created: Thursday, 21 February 2019, 9:14 AM